1.0ETH-Rathttps://ethrat.ch/en/rich600338<blockquote class="wp-embedded-content" data-secret="zwoXraDgYM"><a href="https://ethrat.ch/en/precise-radiation-against-lymphoma/">Precise radiation against lymphoma</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://ethrat.ch/en/precise-radiation-against-lymphoma/embed/#?secret=zwoXraDgYM" width="600" height="338" title="“Precise radiation against lymphoma” — ETH-Rat" data-secret="zwoXraDgYM" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://ethrat.ch/wp-includes/js/wp-embed.min.js /* ]]> */ </script> Image: Aurel Märki PSI Precise radiation against lymphoma Radiopharmaceuticals can target tumour cells locally. Every year, almost 2,000 people in Switzerland are diagnosed with lymphoma, and about 570 of them die from the disease. Researchers at PSI’s Center for Radiopharmaceutical Sciences have now developed an innovative radioimmunotherapy using the nuclide terbium-161. Attached to a suitable ...https://ethrat.ch/wp-content/uploads/2026/03/8_Radionuklid2_def1_RGB1000x600_150px.jpg1000613